Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Stroke

  Free Subscription


Articles published in Heart

Retrieve available abstracts of 59 articles:
HTML format
Text format



Single Articles


    February 2018
  1. FERRARIO MM, Roncaioli M, Veronesi G, Holtermann A, et al
    Differing associations for sport versus occupational physical activity and cardiovascular risk.
    Heart. 2018 Feb 9. pii: heartjnl-2017-312594. doi: 10.1136/heartjnl-2017-312594.
    PubMed     Text format     Abstract available


    December 2017
  2. GNANENTHIRAN SR, Kritharides L, D'Souza M, Lowe HC, et al
    Revascularisation compared with initial medical therapy for non-ST-elevation acute coronary syndromes in the elderly: a meta-analysis.
    Heart. 2017;103:1962-1969.
    PubMed     Text format     Abstract available


  3. OTTO CM
    Heartbeat: Healthcare approaches to reducing adverse outcomes in patients with atrial fibrillation.
    Heart. 2017;103:1925-1927.
    PubMed     Text format    


    November 2017
  4. BAI L, Li Q, Wang J, Lavigne E, et al
    Increased coronary heart disease and stroke hospitalisations from ambient temperatures in Ontario.
    Heart. 2017 Nov 3. pii: heartjnl-2017-311821. doi: 10.1136/heartjnl-2017-311821.
    PubMed     Text format     Abstract available


    August 2017
  5. BOKMA JP, Zegstroo I, Kuijpers JM, Konings TC, et al
    Factors associated with coronary artery disease and stroke in adults with congenital heart disease.
    Heart. 2017 Aug 28. pii: heartjnl-2017-311620. doi: 10.1136/heartjnl-2017-311620
    PubMed     Text format     Abstract available


  6. LIM WY, Lloyd G, Bhattacharyya S
    Mechanical and surgical bioprosthetic valve thrombosis.
    Heart. 2017 Aug 5. pii: heartjnl-2017-311856. doi: 10.1136/heartjnl-2017-311856.
    PubMed     Text format     Abstract available


    June 2017
  7. GHANNAM M, Chugh A
    Indications and appropriate selection of novel oral anticoagulants in patients with atrial fibrillation.
    Heart. 2017 Jun 17. pii: heartjnl-2014-307030. doi: 10.1136/heartjnl-2014-307030
    PubMed     Text format    


  8. ISAEW A, Adderley NJ, Ryan R, Fitzmaurice D, et al
    The treatment of paroxysmal atrial fibrillation in UK primary care.
    Heart. 2017 Jun 1. pii: heartjnl-2016-310927. doi: 10.1136/heartjnl-2016-310927.
    PubMed     Text format     Abstract available


  9. POTPARA TS, Lip GY
    Drug-induced liver injury with oral anticoagulants: a threat or not?
    Heart. 2017;103:809-811.
    PubMed     Text format    


    April 2017
  10. HENDRIKS JM, Gallagher C, Sanders P
    Ensuring adherence to therapy with anticoagulation in patients with atrial fibrillation.
    Heart. 2017 Apr 7. pii: heartjnl-2017-311305. doi: 10.1136/heartjnl-2017-311305.
    PubMed     Text format    


    March 2017
  11. JACKEVICIUS CA, Tsadok MA, Essebag V, Atzema C, et al
    Early non-persistence with dabigatran and rivaroxaban in patients with atrial fibrillation.
    Heart. 2017 Mar 12. pii: heartjnl-2016-310672. doi: 10.1136/heartjnl-2016-310672
    PubMed     Text format     Abstract available


  12. VOUKALIS C, Lip GY
    Oral anticoagulation for elderly patients with non-valvular atrial fibrillation: recent insights from randomised trials and the 'real world'.
    Heart. 2017 Mar 3. pii: heartjnl-2017-311162. doi: 10.1136/heartjnl-2017-311162.
    PubMed     Text format    


  13. CAVALCANTE R, Sotomi Y, Zeng Y, Lee CW, et al
    Coronary bypass surgery versus stenting in multivessel disease involving the proximal left anterior descending coronary artery.
    Heart. 2017;103:428-433.
    PubMed     Text format     Abstract available


    February 2017
  14. LAUW MN, Eikelboom JW, Coppens M, Wallentin L, et al
    Effects of dabigatran according to age in atrial fibrillation.
    Heart. 2017 Feb 17. pii: heartjnl-2016-310358. doi: 10.1136/heartjnl-2016-310358
    PubMed     Text format     Abstract available


    January 2017
  15. OTTO CM
    Heartbeat: Left atrial appendage occlusion for stroke prevention.
    Heart. 2017;103:89-90.
    PubMed     Text format    


  16. KIRCHHOF P
    Integrated care of patients with atrial fibrillation: the 2016 ESC atrial fibrillation guidelines.
    Heart. 2017 Jan 11. pii: heartjnl-2016-310843. doi: 10.1136/heartjnl-2016-310843
    PubMed     Text format    


  17. BLACK-MAIER E, Piccini JP
    Oral anticoagulation in end-stage renal disease and atrial fibrillation: is it time to just say no to drugs?
    Heart. 2017 Jan 9. pii: heartjnl-2016-310540. doi: 10.1136/heartjnl-2016-310540.
    PubMed     Text format    


    December 2016
  18. WILLIAMS RB
    Loneliness and social isolation and increased risk of coronary heart disease and stroke: clinical implications.
    Heart. 2016;102:2016.
    PubMed     Text format    


    November 2016
  19. YANG F, Hellyer JA, Than C, Ullal AJ, et al
    Warfarin utilisation and anticoagulation control in patients with atrial fibrillation and chronic kidney disease.
    Heart. 2016 Nov 15. pii: heartjnl-2016-309266. doi: 10.1136/heartjnl-2016-309266
    PubMed     Text format     Abstract available


    October 2016
  20. BAHIT MC, Lopes RD, Wojdyla DM, Held C, et al
    Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation.
    Heart. 2016 Oct 24. pii: heartjnl-2016-309901. doi: 10.1136/heartjnl-2016-309901
    PubMed     Text format     Abstract available


    September 2016
  21. HEIDBUCHEL H
    The search for the tipping point on when to anticoagulate patients with atrial fibrillation.
    Heart. 2016 Sep 20. pii: heartjnl-2016-310325. doi: 10.1136/heartjnl-2016-310325
    PubMed     Text format    


  22. OU SM, Chen HT, Kuo SC, Chen TJ, et al
    Dipeptidyl peptidase-4 inhibitors and cardiovascular risks in patients with pre-existing heart failure.
    Heart. 2016 Sep 19. pii: heartjnl-2016-309687. doi: 10.1136/heartjnl-2016-309687
    PubMed     Text format     Abstract available


  23. CAMM AJ, Accetta G, Ambrosio G, Atar D, et al
    Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation.
    Heart. 2016 Sep 19. pii: heartjnl-2016-309832. doi: 10.1136/heartjnl-2016-309832
    PubMed     Text format     Abstract available


  24. SWAANS MJ, Boersma LV
    Atrial appendage occlusion for stroke prevention in patients with atrial fibrillation.
    Heart. 2016 Sep 13. pii: heartjnl-2016-310198. doi: 10.1136/heartjnl-2016-310198
    PubMed     Text format    


  25. MAZUREK M, Lip GY
    To occlude or not? Left atrial appendage occlusion for stroke prevention in atrial fibrillation.
    Heart. 2016 Sep 12. pii: heartjnl-2016-310255. doi: 10.1136/heartjnl-2016-310255
    PubMed     Text format    


  26. SAHAY S, Nombela-Franco L, Rodes-Cabau J, Jimenez-Quevedo P, et al
    Efficacy and safety of left atrial appendage closure versus medical treatment in atrial fibrillation: a network meta-analysis from randomised trials.
    Heart. 2016 Sep 1. pii: heartjnl-2016-309782. doi: 10.1136/heartjnl-2016-309782.
    PubMed     Text format     Abstract available


    August 2016
  27. ALLAN V, Banerjee A, Shah AD, Patel R, et al
    Net clinical benefit of warfarin in individuals with atrial fibrillation across stroke risk and across primary and secondary care.
    Heart. 2016 Aug 31. pii: heartjnl-2016-309910. doi: 10.1136/heartjnl-2016-309910
    PubMed     Text format     Abstract available


  28. PURI R, Byrne J, Muller R, Baumbach H, et al
    Transcatheter aortic valve implantation in patients with small aortic annuli using a 20 mm balloon-expanding valve.
    Heart. 2016 Aug 17. pii: heartjnl-2016-309707. doi: 10.1136/heartjnl-2016-309707
    PubMed     Text format     Abstract available


  29. AYABE K, Goto S
    Comparative registries of atrial fibrillation from Japan and the UK: is there a difference between the east and west ends of the Eurasian continent?
    Heart. 2016 Aug 12. pii: heartjnl-2016-310024. doi: 10.1136/heartjnl-2016-310024
    PubMed     Text format    


  30. BERTI S, Pastormerlo LE, Rezzaghi M, Trianni G, et al
    Left atrial appendage occlusion in high-risk patients with non-valvular atrial fibrillation.
    Heart. 2016 Aug 4. pii: heartjnl-2015-309150. doi: 10.1136/heartjnl-2015-309150.
    PubMed     Text format     Abstract available


    June 2016
  31. SENOO K, An Y, Ogawa H, Lane DA, et al
    Stroke and death in elderly patients with atrial fibrillation in Japan compared with the United Kingdom.
    Heart. 2016 Jun 16. pii: heartjnl-2016-309741. doi: 10.1136/heartjnl-2016-309741
    PubMed     Text format     Abstract available


  32. DHILLON A, Khanna A, Randhawa MS, Cywinski J, et al
    Perioperative outcomes of patients with hypertrophic cardiomyopathy undergoing non-cardiac surgery.
    Heart. 2016 Jun 10. pii: heartjnl-2016-309442. doi: 10.1136/heartjnl-2016-309442
    PubMed     Text format     Abstract available


    March 2016
  33. ASSRESS KN, Marciniak M, Marciniak A, Rajani R, et al
    Development of the atrial septum.
    Heart. 2016;102:481-2.
    PubMed     Text format    


  34. ANDERSON RH
    Development of the atrial septum.
    Heart. 2016;102:481.
    PubMed     Text format    


    February 2016
  35. BATRA G, Svennblad B, Held C, Jernberg T, et al
    All types of atrial fibrillation in the setting of myocardial infarction are associated with impaired outcome.
    Heart. 2016 Feb 29. pii: heartjnl-2015-308678. doi: 10.1136/heartjnl-2015-308678
    PubMed     Text format     Abstract available


  36. BREITHARDT G, Baumgartner H, Berkowitz SD, Hellkamp AS, et al
    Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban.
    Heart. 2016 Feb 17. pii: heartjnl-2015-308120. doi: 10.1136/heartjnl-2015-308120
    PubMed     Text format     Abstract available


    January 2016
  37. JAWAD-UL-QAMAR M, Kirchhof P
    Almanac 2015: atrial fibrillation research in Heart.
    Heart. 2016 Jan 20. pii: heartjnl-2015-307809. doi: 10.1136/heartjnl-2015-307809
    PubMed     Text format     Abstract available


  38. VALEUR N, Merie C, Hansen ML, Torp-Pedersen C, et al
    Risk of death and stroke associated with anticoagulation therapy after mitral valve repair.
    Heart. 2016 Jan 4. pii: heartjnl-2015-308272. doi: 10.1136/heartjnl-2015-308272.
    PubMed     Text format     Abstract available


    December 2015
  39. ASRRESS KN, Marciniak M, Marciniak A, Rajani R, et al
    Patent foramen ovale: the current state of play.
    Heart. 2015;101:1916-25.
    PubMed     Text format    


    November 2015
  40. ADAMSON PD, Dweck MR, Newby DE
    The vulnerable atherosclerotic plaque: in vivo identification and potential therapeutic avenues.
    Heart. 2015;101:1755-66.
    PubMed     Text format    


  41. MAHTANI KR, Nunan D, Heneghan C
    Cochrane corner: vitamin K for improved anticoagulation control in patients receiving warfarin.
    Heart. 2015;101:1689-90.
    PubMed     Text format    


    October 2015
  42. ABDEL-QADIR H, Yan AT, Tan M, Borgia F, et al
    Consistency of benefit from an early invasive strategy after fibrinolysis: a patient-level meta-analysis.
    Heart. 2015;101:1554-61.
    PubMed     Text format     Abstract available


    September 2015
  43. AL-ANSARI Y, Otalvaro L, Damluji AA
    Ischaemic stroke after ST-elevation myocardial infarction.
    Heart. 2015 Sep 10. pii: heartjnl-2015-308029. doi: 10.1136/heartjnl-2015-308029
    PubMed     Text format    


    August 2015
  44. KWOK CS, Boekholdt SM, Lentjes MA, Loke YK, et al
    Habitual chocolate consumption and risk of cardiovascular disease among healthy men and women.
    Heart. 2015;101:1279-87.
    PubMed     Text format     Abstract available


    June 2015
  45. CALDEIRA D, Rodrigues FB, Barra M, Santos AT, et al
    Non-vitamin K antagonist oral anticoagulants and major bleeding-related fatality in patients with atrial fibrillation and venous thromboembolism: a systematic review and meta-analysis.
    Heart. 2015 Jun 2. pii: heartjnl-2015-307489. doi: 10.1136/heartjnl-2015-307489.
    PubMed     Text format     Abstract available


  46. OTTO CM
    Heartbeat: Focus on atrial fibrillation.
    Heart. 2015;101:823-5.
    PubMed     Text format    


  47. MINGUEZ JR, Asensio JM, Gragera JE, Costa M, et al
    Two-year clinical outcome from the Iberian registry patients after left atrial appendage closure.
    Heart. 2015;101:877-83.
    PubMed     Text format     Abstract available


  48. ALLI O, Holmes D Jr
    Left atrial appendage occlusion.
    Heart. 2015;101:834-41.
    PubMed     Text format     Abstract available


    May 2015
  49. HASSELL ME, Hildick-Smith D, Durand E, Kikkert WJ, et al
    Antiplatelet therapy following transcatheter aortic valve implantation.
    Heart. 2015 May 6. pii: heartjnl-2014-307053. doi: 10.1136/heartjnl-2014-307053.
    PubMed     Text format     Abstract available


  50. KEACH JW, Bradley SM, Turakhia MP, Maddox TM, et al
    Early detection of occult atrial fibrillation and stroke prevention.
    Heart. 2015 May 2. pii: heartjnl-2015-307588. doi: 10.1136/heartjnl-2015-307588.
    PubMed     Text format     Abstract available


  51. ELBOUDWAREJ O, Wei J, Siegel R
    Diagnosis of an aortic valvular lesion. Non-bacterial thrombotic endocarditis (NBTE).
    Heart. 2015;101:719.
    PubMed     Text format    


    April 2015
  52. STAMBOUL K, Zeller M, Fauchier L, Gudjoncik A, et al
    Prognosis of silent atrial fibrillation after acute myocardial infarction at 1-year follow-up.
    Heart. 2015 Apr 22. pii: heartjnl-2014-307253. doi: 10.1136/heartjnl-2014-307253
    PubMed     Text format     Abstract available


  53. BERTI D, Moors E, Moons P, Heidbuchel H, et al
    Prevalence and antithrombotic management of atrial fibrillation in hospitalised patients.
    Heart. 2015 Apr 14. pii: heartjnl-2014-307059. doi: 10.1136/heartjnl-2014-307059
    PubMed     Text format     Abstract available


    March 2015
  54. DHANA K, Ikram MA, Hofman A, Franco OH, et al
    Anthropometric measures in cardiovascular disease prediction: comparison of laboratory-based versus non-laboratory-based model.
    Heart. 2015;101:377-83.
    PubMed     Text format     Abstract available


  55. FERRARIO MM, Veronesi G
    Aspirin use in women for primary prevention.
    Heart. 2015;101:335-6.
    PubMed     Text format    


    February 2015
  56. YAP SC
    Atrial fibrillation and stroke after atrial septal defect closure. Is earlier closure warranted?
    Heart. 2015 Feb 23. pii: heartjnl-2015-307554. doi: 10.1136/heartjnl-2015-307554
    PubMed     Text format    


  57. NYBOE C, Olsen MS, Nielsen-Kudsk JE, Hjortdal VE, et al
    Atrial fibrillation and stroke in adult patients with atrial septal defect and the long-term effect of closure.
    Heart. 2015 Feb 17. pii: heartjnl-2014-306552. doi: 10.1136/heartjnl-2014-306552
    PubMed     Text format     Abstract available


  58. MOLLMANN H, Kim WK, Kempfert J, Walther T, et al
    Complications of transcatheter aortic valve implantation (TAVI): how to avoid and treat them.
    Heart. 2015 Feb 6. pii: heartjnl-2013-304708. doi: 10.1136/heartjnl-2013-304708.
    PubMed     Text format    


  59. ROY A, Roe MT, Neely ML, Cyr DD, et al
    Impact of Human Development Index on the profile and outcomes of patients with acute coronary syndrome.
    Heart. 2015;101:279-86.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Stroke is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: